Clinical Trial

Epidemiological Landscape of Cervical Cancer in Latin America

Study acronym: EVITA LATAM
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
A portrait of clinical and epidemiological aspects of cervical cancer in Latin America is required to understand the high frequency of cervical cancer despite the existence of effective preventive tools. A better understanding of the current situation of this scenario will provide a valuable groundwork for the development of national and cooperative programs to improve cervical cancer prevention and treatment.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2021-06-24; most recent amendment 2024-07-03.
Status change: Recruiting → Active, Not Recruiting 2023-06-20
Status change: Not Yet Recruiting → Recruiting 2021-11-05
Trial Details
NCT Number NCT04947605
Lead Sponsor Latin American Cooperative Oncology Group
Collaborators: Roche Pharma AG
Conditions Uterine Cervical Neoplasms
Enrollment 524 participants
Start Date 2021-11-04
Primary Completion 2023-03-13 (estimated)
Study Completion 2028-03 (estimated)
Updated on ClinicalTrials.gov 2024-07-05